BAUSCH + LOMB CORP

NYSE: BLCO (Bausch + Lomb Corporation)

Kemas kini terakhir: 4 hari lalu, 11:33PM

21.09

-0.05 (-0.24%)

Penutupan Terdahulu 21.14
Jumlah Dagangan 524,940
Harga / Pendapatan (P/E Ke hadapan) 18.34
Harga / Jualan (P/S) 1.39
Harga / Buku (P/B) 1.17
Julat 52 Minggu
14.44 (-31%) — 21.40 (1%)
Margin Keuntungan -7.50%
Margin Operasi (TTM) -5.36%
EPS Cair (TTM) -1.02
Pertumbuhan Hasil Suku Tahunan (YOY) 3.50%
Jumlah Hutang/Ekuiti (D/E MRQ) 75.07%
Nisbah Semasa (MRQ) 1.56
Aliran Tunai Operasi (OCF TTM) 166.00 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 69.00 M
Pulangan Atas Aset (ROA TTM) 0.61%
Pulangan Atas Ekuiti (ROE TTM) -5.36%

AISkor Stockmoo

1.3
Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info NA
Penilaian Relatif info NA
Pertumbuhan Tersirat info NA
Sejarah Penilaian info NA
Hutang rendah. Keuntungan lemah. Aliran tunai positif. info
Pulangan atas Modal info NA
Daripada analisis teknikal AI kami terhadap carta. info NA
Tiada aliran jelas sepanjang tahun lalu. Didagangkan hampir paras tertinggi 52 minggu. info
Aliran menaik: harga di atas purata bergeraknya, dan purata itu sedang meningkat. Harga telah naik jauh di atas purata itu. Dagangan lebih tinggi pada hari harga naik. info
Corak Lilin info NA
Di atas garis aliran jangka sederhana. info
Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info
Berita terkini kebanyakannya positif. info
Aktiviti Orang Dalam info NA
Institusi bersih -0.28% daripada saham dalam pemfailan 13F terkini: 60 pemegang menambah, 35 mengurang (suku berakhir 30 Sep 2026). info
Persekitaran pasaran berhati-hati. info
Sektor mengatasi prestasi pasaran.
Tonggak-tonggak sependapat, jadi skor diperkukuh.
Harga tinggi berbanding purata 52 minggunya. info
Aliran naik bagi ketiga-tiga tempoh. Momentum jangka pendek meningkat. info
Harga hampir dengan paras rintangan. info
Skor Akhir 1.34
Tunjuk semua

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Bercampur Bercampur
Medical Instruments & Supplies (Global) Bercampur Bercampur
Stok Bausch + Lomb Corporation Bercampur Menaik

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
BLCO - - - 1.17
RMD - 1.08% - 5.66
BDX - 2.20% - 2.41
WST - 0.37% - 9.67
ALC - 0.49% - 1.64
STVN - 0.30% - 2.39

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Mid Core
% Dimiliki oleh Orang Dalam 88.13%
% Dimiliki oleh Institusi 10.97%

Pemilikan

Nama Tarikh Syer Dipegang
Caspian Capital Lp 30 Jun 2026 1,999,043
Glenview Capital Management, Llc 30 Jun 2026 1,918,148
Clark Estates Inc/Ny 30 Sep 2026 881,000

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Institusi

Pemilikan institusi: 10.66%

Kedudukan Pemegang Saham
Bertambah 60 5,333,667
Berkurang 35 5,694,076
Baharu 24 1,736,083
Dijual habis 9 2,368,991

Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.

7 Positif 0 Negatif 2 Neutral
Tarikh Jenis Butiran
14 Nov 2026 Yahoo Finance Bausch + Lomb (BLCO) Following Its Rally Is Fair Value Still In Sight
Bausch + Lomb (BLCO) has been drawing attention after recent trading, with the share price last closing at US$21.09. The move sits against a recent pattern of mixed short term and longer term returns. Over the past month, Bausch + Lomb has seen a sharp shift in momentum, with a 31.48% 30 day share…
13 Nov 2026 Yahoo Finance Bausch + Lomb (BLCO) Stock Still Looks Undervalued Despite Its 35% Run
Bausch + Lomb shares have moved higher in recent months, which puts a sharper spotlight on whether the current US$21.09 price lines up with the cash flows the business can realistically generate. After a solid stretch for the stock, the key issue for anyone looking at Bausch + Lomb today is how…
13 Nov 2026 Yahoo Finance Best Growth Stocks to Buy for November 13th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 13, 2026…
11 Nov 2026 Yahoo Finance Best Growth Stocks to Buy for November 11th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 11, 2026…
06 Nov 2026 Yahoo Finance Zacks.com featured highlights include Repsol, Bausch + Lomb, DMC Global, Universal Logistics and Methanex
Repsol, Bausch + Lomb and three other stocks show strong relative price strength, rising earnings estimates and potential for further gains.
05 Nov 2026 Yahoo Finance Are You Looking for a Top Momentum Pick? Why Bausch + Lomb (BLCO) is a Great Choice
Does Bausch + Lomb (BLCO) have what it takes to be a top stock pick for momentum investors? Let's find out.
04 Nov 2026 Yahoo Finance Bausch + Lomb: 3 Key Takeaways for Long-Term Investors
Premium product adoption is lifting margins faster than revenue growth, a sign of pricing power in a competitive market.
04 Nov 2026 Yahoo Finance Why Bausch + Lomb (BLCO) Might be Well Poised for a Surge
Bausch + Lomb (BLCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
03 Nov 2026 Yahoo Finance BLCO vs. HQY: Which Stock Is the Better Value Option?
BLCO vs. HQY: Which Stock Is the Better Value Option?

Persediaan Teknikal Sederhana

Susunan aliran
Kecerunan
Kemasukan
Dagangan
Aliran menaik: harga di atas purata bergeraknya, dan purata itu sedang meningkat. Harga telah naik jauh di atas purata itu. Dagangan lebih tinggi pada hari harga naik.
Sokongan terdekat: 19.36 – 19.84 · paras sederhana
Rintangan terdekat: 21.20 – 21.56 · paras sederhana

AI Analisis Teknikal

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda